Item 5b UNODC, Drugs, Laboratory and Scientific Services Branch (DLSSB): Thank you, Mr. Chair. distinguished delegates, ladies and gentlemen, as you’re well aware that new psychoactive substances are not under international control, but they produce the same harmful effects as the ones we have under control. In just over a decade, the number of these …
France
Item 3. High-level segment (Friday morning)
Canada: Esteemed Chair, Ministers, Heads of Delegation, Distinguished Delegates, and Civil Society Representatives: Canada is experiencing one of the most serious public health crises in our country’s history: an unrelenting toxic drug and overdose crisis. The impact and scope of the toxic drug crisis is devastating and more complex than ever. Tragically, we have seen …
Opening of the 67th session of the Commission on Narcotic Drugs & Item 3. High-level segment (Thursday morning)
UN Web TV recording Opening of the 67th session of the Commission on Narcotic DrugsOutcome Document: High-level Declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the 2019 Ministerial DeclarationChair: Welcome. Inform you that for the opening session of the HLS, there’ll be a video transmission of the …
CND Thematic Discussions // Session 8 – High transmission of HIV, HCV and other blood-borne diseases associated with drug use
Presenter 1, UNODC: Thank you, Mr. Chair, excellencies, ladies, and gentlemen. I will briefly discuss the lessons learned in the actual UNODC Partnership Project addressing drug use issues in Afghanistan amid the continuing humanitarian crisis. The project received funding support from the European Union for the implementation period 2023 to 2026. Addressing existing fragilities, including …
CND Thematic Discussions / Session 7 – Increase in drug-related deaths – unmet need for drug treatment and health services
Chair: Good morning, everyone. Welcome to the second part of the 2023 Thematic Discussion of the Commission on Narcotic Drugs on the implementation of all international drug policy commitments following the 2019 ministerial declaration (…) Agenda is adopted. Thank you very much. Secretariat: (organizational announcements) Director of the Division of Policy Analysis and Public Affairs …
CND Thematic Discussions // Session 6 – Non-compliance of responses with international drug control conventions & human rights obligations
Chair: Welcome back. The challenge that we will be focusing on this afternoon responses not in conformity with the three international drug conventions, and not in conformity with applicable international human rights obligations pose a challenge to the implementation of joint commitment based on the principle of responsibility. UNODC Scientific Services Branch: I have a brief moment …